| Document Date: 2014-07-15 14:00:38
Open Document File Size: 41,99 KBShare Result on Facebook
City Irvine / Cincinnati / Bristol / Fort Worth / Tampa / / Company Administrator Intellectual Property Department Provider Synergies L.L.C. / Alcon Laboratories / Allergan / Provider Synergies L.L.C. / Monarch Pharmaceuticals / / Country United States / / / Event FDA Phase / / IndustryTerm Search strategy / sulfacetamide solution / pharmaceutical manufacturers / mL solution / / MedicalCondition glaucoma / ocular inflammation / local irritation / secondary ocular infections / anaphylaxis / fungal and viral infections / viral diseases / conjunctivitis / total ocular inflammation / blindness / present infection / corticosteroid-responsive inflammatory ocular conditions / Alcon (ointment) Overview Infections / posterior subcapsular cataract / conjunctival erythema / Serious hypersensitivity / mycobacterial infection / bacterial infection / infection / inflammation / fungal diseases / blepharitis / / MedicalTreatment Antibiotics / / Organization Pharmacy and Therapeutics committee / FDA / Medicaid Agency / / Position physician / / Product Blephamide / dexamethasone / Blephamide S.O.P / FS / gentamicin / polymyxin B sulfate / Cortisporin / Maxitrol / Zylet / neomycin sulfate / All / tobramycin / bacitracin / prednisolone / folic acid / Poly-Pred / Lotemax / Pred-G / Tobradex / hydrocortisone / Indications1 / / ProvinceOrState Texas / Ohio / Tennessee / Florida / California / / Technology Pharmacokinetics / / URL http /
SocialTag |
Microsoft Word - Ophthalmic Antibiotic-Steroid Combinations Mar 10.doc